Table. Patient Characteristics.
| Characteristic | No. (%) |
|---|---|
| Age at diagnosis in years, median (IQR), y | 61.5 (55.3-67.0) |
| Grade group at diagnosis | |
| I | 10 (11.1) |
| II | 13 (14.4) |
| III | 10 (11.1) |
| IV | 17 (18.9) |
| V | 27 (30.1) |
| Unknown | 13 (14.4) |
| PSA at diagnosis, median (IQR) | 15.2 (7.0-84.1) |
| Primary local therapy | |
| Radical prostatectomy | 24 (26.7) |
| External beam radiation therapy | 24 (26.7) |
| Brachytherapy | 10 (11.1) |
| None | 32 (35.5) |
| Ketoconazole dose | |
| 400 mg every 8 h | 75 (83.3) |
| 200 mg every 8 h | 8 (8.9) |
| Unknown | 7 (7.8) |
| HSD3B1 Genotype | |
| Homozygous wild type | 44 (49.0) |
| Heterozygous | 34 (38.0) |
| Homozygous variant | 12 (13.0) |
Abbreviations: IQR, interquartile range; PSA, prostate-specific antigen.